Korro Bio Financial Overview
Korro Bio's market cap is currently $74.21M. The company's EPS TTM is $-1.92; its P/E ratio is -0.84; Korro Bio is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-2.03. See an overview of income statement, balance sheet, and cash flow financials.
